West Nile Virus Vaccine Design by T Cell Epitope Selection: In Silico Analysis of Conservation, Functional Cross-Reactivity with the Human Genome, and Population Coverage

Table 2

Candidate epitope ensemble vaccines with >95% PPC, as calculated by EPISOPT and IEDB.

Ensemble	Method	Peptides		PPC
1	EPISOPT	TLARGFPFV; ITYTDVLRY	GPIRFVLAL	99.00
2	EPISOPT	TLARGFPFV; ITYTDVLRY	GPIRFVLAL; MPNGLIAQF	99.00
3	EPISOPT	TLARGFPFV; TEVMTAVGL; MPNGLIAQF	ITYTDVLRY	99.23
4	EPISOPT	TLARGFPFV; ITYTDVLRY	GPIRFVLAL	97.65
5	IEDB	TLARGFPFV; KSYETEYPK; MPNGLIAQF; AEVEEHRTV; MTTEDMLEVW; RSLFGGMSW	ITYTDVLRY; SYHDRRWCF; GPIRFVLAL	97.34
6	IEDB	TLARGFPFV; KSYETEYPK; MPNGLIAQF; AEVEEHRTV; MTTEDMLEVW	ITYTDVLRY; SYHDRRWCF; GPIRFVLAL	96.81
7	IEDB	TLARGFPFV; KSYETEYPK; MPNGLIAQF; AEVEEHRTV	ITYTDVLRY; SYHDRRWCF; GPIRFVLAL	96.49
8	IEDB	TLARGFPFV; KSYETEYPK; MPNGLIAQF; GPIRFVLAL	ITYTDVLRY; SYHDRRWCF	95.25